Results 11 to 20 of about 23,012 (218)

Low Prevalence of Mumps IgG Antibodies among the Paediatric Population Attending Tertiary Care Hospital in Southern India- A Pilot Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Dear Editor, Mumps is a Vaccine-Preventable Disease (VPD) that can cause self-limiting parotid glands swelling to complicated meningitis, deafness, and infertility.
Aridass Dhanasezhian   +2 more
doaj   +1 more source

Response to Vaccination against Mumps in Medical Students: Two Doses Are Needed

open access: yesViruses, 2021
Mumps is a vaccine-preventable infectious disease diffuse worldwide. The implementation of mumps vaccination reduced largely the spread of infection. On 11,327 Medical School students the prevalence of mumps positive antibodies was evaluated according to
Andrea Trevisan   +6 more
doaj   +1 more source

Close the gap for routine mumps vaccination in Japan

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Mumps is a vaccine-preventable disease. Because the mumps vaccine can cause aseptic meningitis in rare cases, this vaccine is not routine in Japan. This has led to low vaccine coverage and severe disease burden in Japan.
Taito Kitano
doaj   +1 more source

Mumps Vaccines: Current Challenges and Future Prospects

open access: yesFrontiers in Microbiology, 2020
Five decades have passed since the first mumps vaccine was licensed. Over this period, a resurgence of mumps infections has been recorded worldwide. Although global mumps infections have been controlled through vaccination, outbreaks are still on the ...
Iman Almansour
doaj   +1 more source

Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?

open access: yesFrontiers in Immunology, 2020
History illustrates the remarkable public health impact of mass vaccination, by dramatically improving life expectancy and reducing the burden of infectious diseases and co-morbidities worldwide. It has been perceived that if an individual adhered to the
Anna R. Connell   +5 more
doaj   +1 more source

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule.
Dong Li   +8 more
doaj   +1 more source

Genetic Analysis Reveals Differences in CD8+ T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses

open access: yesVaccines, 2021
Nowadays, mumps is re-emerging in highly vaccinated populations. Waning of vaccine-induced immunity plays a role, but antigenic differences between vaccine and mumps outbreak strains could also contribute to reduced vaccine effectiveness.
Patricia Kaaijk   +6 more
doaj   +1 more source

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015

open access: yesVaccines, 2022
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal   +12 more
doaj   +1 more source

An Epidemic of Mumps Reported in a Peripheral Charitable Hospital, Bengaluru, Karnataka [PDF]

open access: yesPediatric Infectious Disease
Mumps is a highly contagious, vaccine-preventable disease. It is one of the oldest human illnesses known to humans. Mumps is caused by paramyxovirus, which is a single-stranded ribonucleic acid (RNA) virus. It is a self-limited illness.
Sreepriya Lalitha, Minnie R
doaj   +1 more source

High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Background During the period of immunization with a single-dose measles-mumps-rubella (MMR) vaccine, which has been available since 2008in China, the incidence of mumps in children aged 2–5 years has been high.
Xiang Sun   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy